Clinical utility and technical pitfalls of the serum free light chain (FLC) assay for monitoring of monoclonal light-chain diseases

被引：0
|
作者：
Tate, J. R.
Mollee, P.
Carter, A.
Gill, D.
机构：
[1] Herston Hosp, Brisbane, Qld, Australia
[2] Princess Alexandra Hosp, Brisbane, Qld, Australia
来源：
CLINICAL CHEMISTRY | 2006年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
E44
引用
收藏
页码：A178 / A178
页数：1
相关论文
共 50 条
  • [21] Immunoglobulin light-chain toxicity in a mouse model of monoclonal immunoglobulin light-chain deposition disease
    Bender, Sebastien
    Ayala, Maria Victoria
    Bonaud, Amelie
    Javaugue, Vincent
    Carrion, Claire
    Oblet, Christelle
    Rinsant, Alexia
    Kaaki, Sihem
    Oruc, Zeliha
    Boyer, Francois
    Paquet, Agnes
    Pons, Nicolas
    Herve, Bastien
    Ashi, Mohamad Omar
    Jaccard, Arnaud
    Delpy, Laurent
    Touchard, Guy
    Cogne, Michel
    Bridoux, Frank
    Sirac, Christophe
    [J]. BLOOD, 2020, 136 (14) : 1645 - 1656
  • [22] Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: Correlation with 24-hr urinary light-chain excretion
    Alyanakian, MA
    Abbas, A
    Delarue, R
    Arnulf, B
    Aucouturier, P
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2004, 75 (04) : 246 - 248
  • [23] Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma
    Drayson, M
    Tang, LX
    Drew, R
    Mead, GP
    Carr-Smith, H
    Bradwell, AR
    [J]. BLOOD, 2001, 97 (09) : 2900 - 2902
  • [24] Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment Reply
    Jacobs, Joannes F. M.
    Hoedemakers, Rein M. J.
    te Velthuis, Henk
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (11) : E247 - E248
  • [25] Nonamyloidotic monoclonal immunoglobulin deposition disease - Light-chain, heavy-chain, and light- and heavy-chain deposition diseases
    Buxbaum, J
    Gallo, G
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) : 1235 - +
  • [26] COMPARISON OF THE FREELITE™ SERUM FREE LIGHT CHAIN (SFLC) ASSAY WITH SERUM AND URINE ELECTROPHORESIS/IMMUNOFIXATION AND THE N LATEX FLC ASSAY
    Sasson, Sarah C.
    McGill, Kate
    Weinholt, Louise
    Carr, Andrew
    Brown, David A.
    Kelleher, Anthony D.
    Breit, Samuel N.
    Sewell, William A.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 : 24 - 24
  • [27] Novel Assay for Quantification of Free Light Chain (FLC) Dimers in Serum of Patients with Plasma Cell Dyscrasias
    Liyasova, Mariya
    Slade, Michael
    Fortier, Julie
    Vij, Ravi
    Fiala, Mark
    Yang, Liqiang
    Ma, Bin
    [J]. BLOOD, 2023, 142
  • [28] Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay
    Sasson, S. C.
    McGill, K.
    Wienholt, L.
    Carr, A.
    Brown, D. A.
    Kelleher, A. D.
    Breit, S. N.
    Sewell, W. A.
    [J]. PATHOLOGY, 2015, 47 (06) : 564 - 569
  • [29] Clinical Comparison of a New Serum Free Light Chain (FLC) Assay Based on the Seralite Monoclonal Anti-FLC Antibodies with the Freelite and N-Latex FLC Assays in the Diagnosis of AL Amyloidosis
    Mollee, Peter
    Pretorius, Carel
    Drayson, Mark T.
    Tate, Jill
    [J]. BLOOD, 2017, 130
  • [30] Heavy/Light-Chain Analysis of Monoclonal Gammopathies
    Keren, David F.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (09) : 1606 - 1608
12345